Progression of ischaemic stroke and excitotoxic aminoacids

Lancet

Volumn 349, Issue 9045, 1997, Pages 79-82

  Castillo, José ^a   Dávalos, Antoni ^b   Noya, Manuel ^a  

^a HOSPITAL GENERAL DE GALICIA   (Spain)

^b HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EXCITATORY AMINO ACID; GLUTAMIC ACID; GLYCINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BRAIN EDEMA; BRAIN ISCHEMIA; CEREBROSPINAL FLUID; CEREBROVASCULAR ACCIDENT; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STROKE;

EID: 0031033912     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)04453-4     Document Type: Article

References (25)

1. Dávalos A, Cendra E, Teruel J, Martinez M, Genis D. Deteriorating ischemic stroke: risk factors and prognosis. Neurology 1990; 40: 1865-69.
2. Toni D, Fiorelli M, Gentile M, et al. Progressing neurological deficit secondary to acute ischemic stroke: a study on predictability, pathogenesis and prognosis. Arch Neurol 1995; 52: 670-75.
3. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Effect of blood pressure and diabetes on stroke in progression. Lancet 1994; 344: 156-59.
4. Britton M, Röden A. Progression of stroke after arrival at hospital. Stroke 1985; 16: 629-32.
5. Asplund K. Deterioration of acute stroke. In: del Zoppo GJ, Mon E, Hacke W, eds. Thrombolytic therapy in actue ischemic stroke II. Berlin: Springer-Verlag, 1993: 119-28.
6. Hossmann KA. Mechanisms of ischemic injury: is glutamate involved? In: Krieglstein J, Oberpichler-Schwenk H, eds. Pharmacology of cerebral ischemia 1994. Stuttgart: Medpharm, 1994: 239-51.
7. Siesjo BK. Pathophysiology and treatment of focal cerebral ischemia: part I: pathophysiology. J Neurosurg 1992; 77: 169-84.
8. Hossmann KA. Glutamate-mediated injury in focal cerebral ischemia: the excitotoxin hypothesis revised. Brain Pathol 1994; 4: 23-36.
9. Takagi K, Ginsberg MD, Globus MYT, et al. Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbral region following middle cerebral artery occlusion in the rat: correlation with histopatahology. J Cereb Blood Flow Metab 1993; 13: 575-85.
10. Butcher SP, Bullock R, Graham DI, McCulloch J. Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion. Stroke 1990; 21: 1727-33.
11. Matsumoto K, Graf R, Rosner G, Taguchi J, Heiss WD. Elevation of neuroactive substances in the cortex of cats during prolonged focal ischemia. J Cereb Blood Flow Metab 1993; 13: 586-94.
12. Johnson JW, Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 1987; 325: 529-31.
13. Adams HP, Bendixen BH, Kappelle LJ, et al, and the TOAST Investigators. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 1993; 24: 35-41.
14. Côté R, Hachinski VC, Shervell BL, Morris JW, Wolfson C. The Canadian neurological scale: a preliminary study in acute stroke. Stroke 1986; 17: 731-37.
15. Spackman DH, Stein WH, Moore S. Automatic recording apparatus for use in the chromatography of amino acids. Anal Chem 1958; 30: 1190-1206.
16. Robert C, Vermont J, Bosson JL. Formulas for threshold computations. Comput Biomed Res 1991; 24: 514-29.
17. Gautier JC. Stroke-in-progression. Stroke 1985; 16: 729-33.
18. Rothman SM, Olney JW. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 1986; 19: 105-11.
19. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994; 330: 614-21.
20. Sage JI, van Uitert RL, Duffy TE. Early changes in blood brain barrier permeability to small molecules after transient cerebral ischemia. Stroke 1984; 15: 46-50.
21. Del Zoppo GJ. Microvascular changes during cerebral ischemia and reperfusion. Cerebrovasc Brain Metab Rev 1994; 6: 47-96.
22. Tominaga T, Suzuki H, Mizuno H, et al. Clinical significance of measuring plasma concentrations of glutamine and glutamate in alcoholic liver diseases. Alcohol Alcohol Suppl 1993; 1AP: 103-09.
23. Ollenschlager G, Karner J, Kamer-Hanusch J, Jansen S, Schindler J, Roth E. Plasma glutamate - a prognostic marker of cancer and of other immunodeficiency syndromes? Scand J Clin Lab Invest 1989; 49: 773-77.
24. Castillo J, Dévalos A, Naveiro J, Noya M. Neuroexcitatory amino acids and their relationship to infarct size and neurological deficit in ischemic stroke. Stroke 1996; 27: 1060-65.
25. Baker CJ, Fiore AJ, Frazzini VI, Choudhri TF, Zubay GP, Solomon RA. Intraischemic hypothermia decreases the release of glutamate in the cores of permanent focal cerebral infarcts. Neurosurgery 1995; 36: 994-1002.